CNA Diagnostics careers

CNA Diagnostics Inc. is a molecular diagnostics company with a biomarker platform capable of detecting multiple human and animal diseases, long before clinical signs are evident.
- Significant potential for commercialization of human Sepsis test. Initial trial 100% accurate, identifying the disease days before clinical symptoms appeared in 22 patients.
- The test results are DEFINITIVE, not predictive.
- The test development process is standardized, repeatable, and scalable.
- To date 100% success rate in the identification of four diseases in humans, rats, elk and cattle.
- Building a portfolio of commercial tests to diagnose highest impact diseases: bovine, porcine, equine, canine, feline, and human.
- License agreement in place for the commercialization of CNA’s Johnes Disease test (almost completed) with Maymo for 67 countries.
- At present there is no other known group developing a similar technology.